Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:1644-1650

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ujhelyi, M. R.
Right arrow Articles by Markel, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ujhelyi, M. R.
Right arrow Articles by Markel, M. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIDOCAINE

(Circulation. 1995;92:1644-1650.)
© 1995 American Heart Association, Inc.


Articles

Differential Effects of Lidocaine on Defibrillation Threshold With Monophasic Versus Biphasic Shock Waveforms

Michael R. Ujhelyi, PharmD; Michael Schur, BS; Thomas Frede, RN; Marjorie Gabel; Michael L. Markel, MD

From the University of Georgia College of Pharmacy and Medical College of Georgia School of Medicine (M.R.U.) (Augusta); and the University of Cincinnati Medical Center Colleges of Pharmacy and Medicine (M.R.U., M.S., T.F., M.G., M.L.M.), Cincinnati, Ohio.

Correspondence to Dr Michael Ujhelyi, Medical College of Georgia, Rm FI-1087, Augusta, GA 30912-2390.

Background Defibrillation waveforms and antiarrhythmic drugs have disparate effects on myocardial excitability and refractoriness, making it likely that antiarrhythmic drugs will interact with one waveform differently than with another. The aim of the present study was to determine if the increase in defibrillation threshold (DFT) induced by lidocaine is similar for electrical shocks with monophasic and biphasic waveforms.

Methods and Results Twenty-six pentobarbital-anesthetized farm-raised pigs were instrumented with pacing catheters and epicardial defibrillation electrodes. Each pig was assigned to one of four groups: (1) monophasic shock waveform and placebo (5% dextrose in water [D5W]) (n=7), (2) monophasic shock waveform and lidocaine (n=7), (3) biphasic shock waveform and placebo (D5W) (n=5), or (4) biphasic shock waveform and lidocaine (n=7). DFT was measured at baseline and subsequently during treatment (D5W or lidocaine). In the monophasic waveform groups, DFT increased from baseline in response to lidocaine by 92% (P<.0001), whereas DFT values in response to D5W did not change. In the biphasic waveform groups, DFT values did not change from baseline in response to lidocaine (P=NS), whereas DFT values from baseline in response to D5W significantly decreased by 29% (P=.04). In the monophasic waveform groups, the change in DFT from baseline in response to lidocaine was significantly different than the change from baseline in response to D5W (92±29% versus -0.5±29%, respectively) (P<.0002). In the biphasic waveform groups, however, the change in DFT from baseline in response to lidocaine was similar to the change from baseline in response to D5W (-5.66±15% versus -29±17%, respectively) (P=.48). Furthermore, the change in DFT from baseline in response to lidocaine differed significantly between monophasic and biphasic waveform groups (92±29% versus -5.66±15%) (P<.0002), whereas the change from baseline in response to D5W did not differ between monophasic and biphasic waveforms (-0.5±29% versus -29±17%) (P=.34).

Conclusions Compared with placebo groups, DFT values increased during lidocaine treatment to a much greater degree in the monophasic waveform group than in the biphasic waveform group receiving lidocaine. These data support our hypothesis that antiarrhythmic drugs can affect the defibrillation efficacy of monophasic waveforms differently than that of biphasic waveforms.


Key Words: defibrillation • waves • lidocaine • antiarrhythmia agents




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Materazzo, P. Piotti, C. Mantovani, R. Miceli, and F. Villani
Atrial fibrillation after non-cardiac surgery: P-wave characteristics and Holter monitoring in risk assessment
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. J. Sims, K. L. Schoff, J. M. Loeb, and N. A. Wiegert
Regional gap junction inhibition increases defibrillation thresholds
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H10 - H16.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Ujhelyi, J. J. Sims, and A. W. Miller
Induction of Electrical Heterogeneity Impairs Ventricular Defibrillation : An Effect Specific to Regional Conduction Velocity Slowing
Circulation, December 21, 1999; 100(25): 2534 - 2540.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D A Chamberlain
Antiarrhythmic drugs in resuscitation
Heart, October 1, 1998; 80(4): 408 - 411.
[Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. J. Sims, A. W. Miller, and M. R. Ujhelyi
Disparate effects of biphasic and monophasic shocks on postshock refractory period dispersion
Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1943 - H1949.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. O. Cummins, M. F. Hazinski, R. E. Kerber, P. Kudenchuk, L. Becker, G. Nichol, B. Malanga, T. P. Aufderheide, E. M. Stapleton, K. Kern, et al.
Low-Energy Biphasic Waveform Defibrillation: Evidence-Based Review Applied to Emergency Cardiovascular Care Guidelines : A Statement for Healthcare Professionals From the American Heart Association Committee on Emergency Cardiovascular Care and the Subcommittees on Basic Life Support, Advanced Cardiac Life Support, and Pediatric Resuscitation
Circulation, April 28, 1998; 97(16): 1654 - 1667.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Ujhelyi, J. J. Sims, and A. W. Miller
High-dose lidocaine does not affect defibrillation efficacy: implications for defibrillation mechanisms
Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1113 - H1120.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
A. P. Winecoff, J. J. Sims, M. L. Markel, and M. R. Ujhelyi
Pinacidil's Effects on Defibrillation Outcomes: Role of Increased Potassium Conductance Via the KATP Channel
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(3): 171 - 180.
[Abstract] [PDF]


Home page
CirculationHome page
G. H. Bardy, F. E. Marchlinski, A. D. Sharma, S. J. Worley, R. M. Luceri, R. Yee, B. D. Halperin, C. L. Fellows, T. S. Ahern, D. A. Chilson, et al.
Multicenter Comparison of Truncated Biphasic Shocks and Standard Damped Sine Wave Monophasic Shocks for Transthoracic Ventricular Defibrillation
Circulation, November 15, 1996; 94(10): 2507 - 2514.
[Abstract] [Full Text]